COVID-19 and Neuroendocrine Tumors

How is COVID-19 affecting those living with neuroendocrine tumors? Dr. Mark Lewis, Intermountain Healthcare talks with NETRF Chief Executive Office Elyse Gellerman to answer the most common questions and concerns of NET patients and family members on April 3, 2020. _______ is a leading funder of neuroendocrine tumor research in the U.S. and abroad. As a nonprofit foundation, NETRF is also committed to educating patients and families about #NeuroendocrineCancer with: - Live patient conferences